ABSTRACT
Objectives To develop an accurate, state-of-the-art algorithm for the incidental detection of pancreatic cystic lesions (PCLs) on computerized tomography (CT) and magnetic resonance imaging (MRI) scans.
Methods A SwinT-Unet-based architecture was developed for the incidental detection of PCLs. The algorithm was trained and validated on a robust dataset of retrospective CT and MRI studies collected from HT Médica centers located in eight different cities using scanners fabricated by four different manufacturers.
Results Our algorithm was able to detect 91.6% of the confirmed PCLs in the initial dataset with 91.6% sensitivity and 92.3% specificity, while 91.7% of the healthy controls were also correctly identified. Furthermore, our tool was remarkably capable of classifying these PCLs as mucinous or non-mucinous, determining their location within the pancreas with an accuracy of 88.5%, and identifying the presence of calcifications or scars within the PCLs with an accuracy of 96%.
Conclusions By integrating radiological data and state-of-the-art artificial intelligence techniques, we have developed an efficient tool for the incidental identification and initial characterization of PCLs, which present a substantial prevalence within the global population. Our algorithm facilitates early diagnosis of pancreatic abnormalities, which could have a profound impact on patient management and prognosis, particularly in the case of PCLs with malignant potential.
Competing Interest Statement
M. Alvaro Berbis is the CEO of Cells IA Technologies. Antonio Luna received institutional royalties and institutional payments for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Canon, Bracco, Siemens Healthineers, and Philips Healthcare and is a board member of Cells IA Technologies. Julia Rodriguez-Comas is the CTO of Sycai Technologies. The remaining authors have no competing interests to declare that are relevant to the content of this article.
Funding Statement
This project was co-financed by the European Union (NextGenerationEU) through the Public Business Entity Red.es, affiliated to the Secretaria de Estado de Digitalizacion e Inteligencia Artificial, Ministerio de Asuntos Economicos y Transformacion Digital (Secretary of State for Digitalization and Artificial Intelligence, Ministry of Economic Affairs and Digital Transformation) within the framework of the 2021 Call for Aid for research and development projects in artificial intelligence and other digital technologies and their integration into value chains (C005/21-ED call, project reference 2021/C005/00153960).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was performed in accordance with the ethical standards in the 1964 Declaration of Helsinki. The protocol followed in this study was approved by the Institutional Review Board of HT Medica.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data used in this study are not openly available due to commercial and proprietary constraints. Access to the data may be granted by the corresponding author upon reasonable request and subject to confidentiality agreements.
